南方医药保健灵活配置混合A(000452)利润分配表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 收入 |
716,342,552.08 |
443,320,263.69 |
-379,030,298.57 |
-281,887,448.28 |
| 利息合计 |
1,228,751.60 |
361,008.98 |
2,032,589.70 |
1,245,979.86 |
| 其中:存款利息收入 |
475,318.50 |
106,946.68 |
523,523.38 |
249,361.82 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
753,433.10 |
254,062.30 |
1,509,066.32 |
996,618.04 |
| 投资收益合计 |
782,088,038.56 |
262,596,830.30 |
-287,718,185.30 |
-228,837,730.29 |
| 其中:股票投资收益 |
766,616,460.83 |
252,135,024.06 |
-323,240,295.67 |
-253,669,554.40 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
1,350,101.59 |
502,534.11 |
3,403,850.30 |
1,612,306.56 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
14,121,476.14 |
9,959,272.13 |
32,118,260.07 |
23,219,517.55 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-68,266,528.76 |
179,860,569.60 |
-94,248,239.31 |
-54,536,680.60 |
| 其他收入 |
1,292,290.68 |
501,854.81 |
903,536.34 |
240,982.75 |
| 费用 |
33,935,550.73 |
15,842,520.44 |
39,411,713.28 |
19,028,646.42 |
| 管理人报酬 |
28,611,574.84 |
13,415,417.98 |
33,462,339.93 |
16,148,961.07 |
| 基金托管费 |
4,768,595.87 |
2,235,903.02 |
5,577,056.67 |
2,691,493.59 |
| 销售服务费 |
290,293.10 |
55,163.38 |
115,618.53 |
58,129.28 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
265,086.92 |
136,036.06 |
256,697.76 |
130,062.09 |
| 利润总额 |
682,407,001.35 |
427,477,743.25 |
-418,442,011.85 |
-300,916,094.70 |